Sera Prognostics Q1 net loss narrows to $8.1M; net revenue nil after adjustments

SERA PROGNOSTICS, INC.

2024-Q1 EPS reported -$0.25

Net revenue nil after periodic review of accounting estimates for older tests; gross revenue $39K vs $100K YoY.
Net loss $8.1M, improved 24% from $10.6M loss in Q1 2023.
Operating expenses $9.1M, down 20% YoY; SG&A $5.4M (-26%), R&D $3.7M (-10%).
Shipped first ambient whole blood collection kits to reduce COGS and expand access.
Submitted PRIME study interim analysis manuscript for peer-reviewed publication.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SERA PROGNOSTICS, INC. reported first quarter ended March 31, 2024 results: revenue nil, net income $8.1 million loss.

Period: first quarter ended March 31, 2024
Revenue: nil
Net income: $8.1 million loss
Result: reported results

Exact text from the filing

First quarter 2024 revenue before adjustments was $39,000 compared to $100,000 for the same period of 2023, but net revenue was nil after our periodic review of accounting estimates for older tests.

View on SEC.gov

Browse all earnings releases →

SERA PROGNOSTICS, INC. filing history →

Source: SEC EDGAR

accession 0001534969-24-000084

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.